Under homoeostasis, CD163 scavenges haptoglobin–haemoglobin complexes [90], and in cancer, CD163 is a widely known marker for tumour-promoting M2-like macrophages, generally associated with poor prognosis [83, 91, 92]. The gene discussed is CD163; the disease is cancer.